🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Long-term Safety Trial with NVDX3

RecruitingPhase 1, Phase 2Ages 18 Years - anyAllNovadip Biosciences
NCT06532253 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

An study evaluating the long-term safety of all patients previously treated with NVDX3.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Patient being implanted with NVDX3. 2. Previously participated to one of the NVDX3 core clinical trials. 3. Patient accepts to comply to a yearly follow-up safety visit for 10 additional years 4. Patient has understood and accepted to participate in the long-term follow-up study by signing the informed consent. Exclusion Criteria: No exclusion criteria are applicable.
💊

What it tests

  • NVDX3
📍

Where

1 site
Centre Hospitalier de Luxembourg
Luxembourg, Luxembourg
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy